Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

548
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
548
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

905
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
905
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

992
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
992
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

976
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
976
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

654
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
654
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Normative face recognition ability test scores vary across online participant pools.

Scientific reports·2025
Same author

THE EFFECTS OF ENDOCRINE DISRUPTORS ON FEMALE GONADAL AXIS: AN UPDATE.

Acta endocrinologica (Bucharest, Romania : 2005)·2023
Same author

Free radical-decellularized tissue promotes enhanced antioxidant and anti-inflammatory macrophage response.

Biomaterials·2019
Same author

Sharing of prescription analgesics amongst patients in family practice: Frequency and associated factors.

European journal of pain (London, England)·2017
Same author

[ANEMIA IN CHRONIC KIDNEY DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[DIET CHARACTERISTICS IN PATIENTS WITH CHRONIC KIDNEY DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[CHARACTERISTIC FEATURES OF PRESSURE ULCER INFECTION].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PERSONALIZED APPROACH TO PATIENT WITH CHRONIC WOUND IN FAMILY MEDICINE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF TOPICAL HEMOGLOBIN SPRAY IN INFECTED POSTTRAUMATIC AND POSTOPERATIVE WOUNDS].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF NEGATIVE PRESSURE THERAPY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PATIENTS WITH PRESSURE ULCERS IN THE UNIFIED EMERGENCY ADMISSION DEPARTMENT – OUR REALITY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[Proposition of algorhythm for treatment with hyperbaric oxygenation Hyperbaric oxygenation in Rijeka Clinical Hospital Center].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

857

[PATIENT WITH PEPTIC ULCER DISEASE].

N Radošević Quadranti, I Diminić-Lisica, N Bašić Marković

    Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
    |October 31, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Peptic ulcer disease, often caused by Helicobacter pylori infection or NSAID use, requires prompt diagnosis and treatment. Testing for H. pylori infection is recommended for dyspepsia patients, with specific diagnostic and treatment guidelines based on age and alarm symptoms.

    More Related Videos

    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
    03:05

    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

    Published on: February 16, 2024

    1.6K
    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
    06:40

    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

    Published on: June 29, 2019

    7.1K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
    05:23

    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

    Published on: March 7, 2025

    857
    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
    03:05

    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

    Published on: February 16, 2024

    1.6K
    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
    06:40

    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

    Published on: June 29, 2019

    7.1K

    Area of Science:

    • Gastroenterology
    • Internal Medicine
    • Microbiology

    Background:

    • Peptic ulcer disease (PUD) arises from an imbalance in the digestive tract's mucosal defense and aggressive factors.
    • Key external triggers for PUD include Helicobacter pylori infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA).
    • Dyspeptic symptoms are a frequent reason for primary care consultations, necessitating clear diagnostic pathways.

    Purpose of the Study:

    • To outline diagnostic and management strategies for peptic ulcer disease.
    • To define appropriate testing and treatment protocols for Helicobacter pylori infection in patients presenting with dyspepsia.

    Main Methods:

    • Recommends Urea Breath Test or stool antigen testing for H. pylori in patients under 50 without alarm symptoms.
    • Mandates endoscopic examination for patients over 50 or those with alarm symptoms.
    • Outlines first-line eradication therapies including sequential or triple therapy (PPI, amoxicillin, metronidazole).

    Main Results:

    • H. pylori infection should be treated upon confirmation.
    • Eradication therapy is followed by a control test for H. pylori four weeks post-treatment.
    • Age and alarm symptoms dictate the diagnostic approach (testing vs. endoscopy).

    Conclusions:

    • Timely diagnosis and targeted H. pylori eradication are crucial for managing peptic ulcer disease.
    • Adherence to recommended diagnostic and therapeutic guidelines ensures effective PUD management.
    • Follow-up testing confirms successful eradication, preventing recurrence.